Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in…
In the MAXA trial, standalone MagnetOs outperformed the gold standard autograft by 73% in posterior spinal fusion in…
Die neue ELinOS-Version 7.1 und das dazugehörige Build-Environment des deutschen Embedded-Software-Spezialisten SYSGO ma…
ipoque GmbH, a Rohde & Schwarz company, today announced the launch of R&S®vPACE, its vector packet processing (VPP)-nati…
Today, ipoque, a Rohde & Schwarz company and an industry-leading provider of OEM deep packet inspection (DPI) software,…
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral thera…
ISA Pharmaceuticals B.V., a clinical-stage company dedicated to the development of rationally designed immunotherapeutic…
. . - FDA has granted IND approval for Immunic’s oral investigational drug IMU-838 - Active IND allows Immunic to proce…
Auf einen Blick: Technologiepartnerschaft mit LGS Innovations liefert erstklassige Kombination aus Netzwerkinfrastru…
BIOTRONIK, a leading manufacturer of cardio- and endovascular medical technology, today announced the first patient enro…
Das Forschungsteam Unit 42 von Palo Alto Networks beobachtet ein neues Remote Access Tool (RAT). Das RAT namens uWarrior…